Expand Energy Corp Class C Warrants
EXEEL
EXEEL was delisted on the 6th of February, 2026.
0 hedge funds and large institutions have $0 invested in Expand Energy Corp Class C Warrants in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.
4.1% less ownership
Funds ownership: 4.1% → 0% (-4.1%)
100% less funds holding
Funds holding: 50 → 0 (-50)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $45.8M → $0 (-$45.8M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 48
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$19.5M |
| 2 |
OCM
Oaktree Capital Management
Los Angeles,
California
|
-$9.5M |
| 3 |
OGM
OnyxPoint Global Management
New York
|
-$8.48M |
| 4 |
CL
CSS LLC
Chicago,
Illinois
|
-$1.24M |
| 5 |
GCM
Glendon Capital Management
Santa Monica,
California
|
-$930K |
EXEEL Hedge Fund Activity: Q1 2026 in Review
0 of the 8,159 institutional investors tracked by Wall St. Rank reported a position in Expand Energy Corp Class C Warrants (EXEEL) for Q1 2026, worth a combined $0 — down 100% from $45.8M a quarter earlier.
Sellers outnumbered buyers: 48 funds closed out of EXEEL and 0 opened new positions — a net loss of 48 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was VOYA Investment Management, exiting entirely with an estimated $19.5M sold.
- 0 institutional investors held Expand Energy Corp Class C Warrants (EXEEL) as of Q1 2026, down from 50 in Q4 2025.
- Funds reported $0 of Expand Energy Corp Class C Warrants stock for Q1 2026, down 100% quarter-over-quarter.
- 0 funds opened new Expand Energy Corp Class C Warrants positions in Q1 2026 and 48 closed out, a net change of -48 holders.
- The largest Expand Energy Corp Class C Warrants seller in Q1 2026 was VOYA Investment Management, an estimated $19.5M sold.
Based on aggregated 13F filings for Q1 2026.